Testing block subdivision algorithms on block designs

Nat Wiseman,Z. Patterson

DOI: https://doi.org/10.1007/s10109-015-0222-6

Journal of Geographical Systems

Abstract:

What problem does this paper attempt to address?

An omics review and perspective of researches on intrahepatic cholestasis of pregnancy

Min Wang,Lingyan Chen,Jingyang Li,Yilan You,Zhiwen Qian,Jiayu Liu,Ying Jiang,Tao Zhou,Ying Gu,Yan Zhang

DOI: https://doi.org/10.3389/fendo.2023.1267195

IF: 6.055

2024-01-08

Frontiers in Endocrinology

Abstract:Intrahepatic cholestasis of pregnancy (ICP) is one of the common pregnancy complications that may threaten the health of both pregnant women and their fetuses. Hence, it is of vital importance to identify key moleculars and the associated functional pathways of ICP, which will help us to better understand the pathological mechanisms as well as to develop precise clinical biomarkers. The emerging and developing of multiple omics approaches enable comprehensive studies of the genome, transcriptome, proteome and metabolome of clinical samples. The present review collected and summarized the omics based studies of ICP, aiming to provide an overview of the current progress, limitations and future directions. Briefly, these studies covered a broad range of research contents by the comparing of different experimental groups including ICP patients, ICP subtypes, ICP fetuses, ICP models and other complications. Correspondingly, the studied samples contain various types of clinical samples, in vitro cultured tissues, cell lines and the samples from animal models. According to the main research objectives, we further categorized these studies into two groups: pathogenesis and diagnosis analyses. The pathogenesis studies identified tens of functional pathways that may represent the key regulatory events for the occurrence, progression, treatment and fetal effects of ICP. On the other hand, the diagnosis studies tested more than 40 potential models for the early-prediction, diagnosis, grading, prognosis or differential diagnosis of ICP. Apart from these achievements, we also evaluated the limitations of current studies, and emphasized that many aspects of clinical characteristics, sample processing, and analytical method can greatly affect the reliability and repeatability of omics results. Finally, we also pointed out several new directions for the omics based analyses of ICP and other perinatal associated conditions in the future.

endocrinology & metabolism
Unexplored topics in intrahepatic cholestasis of pregnancy: A review and bibliometric analysis

Qing Hu,Haiyan Yu

DOI: https://doi.org/10.1097/md.0000000000039972

IF: 1.6

2024-10-30

Medicine

Abstract:Intrahepatic cholestasis of pregnancy (ICP) is a complication that occurs in 0.2% to 2% of pregnancies, [ 1 ] and is characterized and diagnosed by pruritus and elevated maternal total serum bile acid concentrations in pregnant women. [ 2 , 3 ] Stillbirth, as an adverse neonatal outcome, was demonstrated to be associated with maximal total bile acid concentration; and the prevalence of stillbirth in singletons varies from 0.28% to 3.44% when the serum bile acid varies between 40 and 100 μmol/L or more. [ 4 ]

medicine, general & internal
Intrahepatic cholestasis of pregnancy: insights into pathogenesis and advances in omics studies

Mi Tang,Liling Xiong,Jianghui Cai,Jinzhu Fu,Hong Liu,Ying Ye,Li Yang,ShaSha Xing,Xiao Yang

DOI: https://doi.org/10.1007/s12072-023-10604-y

Abstract:Intrahepatic cholestasis of pregnancy (ICP) is the most common pregnancy-specific liver disease. It is characterized by pruritus, abnormal liver function and elevated total bile acid (TBA) levels, increasing the risk of maternal and fetal adverse outcomes. Its etiology remains poorly elucidated. Over the years, various omics techniques, including metabolomics, microbiome, genomics, etc., have emerged with the advancement of bioinformatics, providing a new direction for exploring the pathogenesis, diagnosis and treatment of ICP. In this review, we first summarize the role of bile acids and related components in the pathogenesis of ICP and then further illustrate the results of omics studies.
Systematic review and meta-analysis: Evaluating the influence of intrahepatic cholestasis of pregnancy on obstetric and neonatal outcomes

Xuexia Huang,Huifeng Gu,Pinghua Shen,Xiaoxing Zhang,Anping Fei

DOI: https://doi.org/10.1371/journal.pone.0304604

IF: 3.7

2024-06-05

PLoS ONE

Abstract:Intrahepatic cholestasis of pregnancy (ICP) is a serious liver conditions that negatively impacts obstetric and neonatal outcomes. Elevated levels of bile acid, particularly glycine conjugate, may compromise blood flow and cause functional hypoxia-ischemia. This meta-analysis aims to assess the association between ICP and key pregnancy outcomes including emergency caesarian sections (C-sections), preeclampsia, hemorrhage, preterm birth, small for gestational age, admission rate to neonatal intensive care union (NICU), gestational age, and stillbirth. Literature search across five databases (PubMed, Embase, Web of Science) was done to detect relevant studies published up until June 2023. Meta-analysis of the identified studies was done using a random-effects model, and the results presented as Odds ratio (OR). A literature search identified 662 studies. Of them, 21 met the inclusion criteria. There was a significant association between ICP and odds of C-section (OR: 1.42, p <0.001), preeclampsia (OR: 2.64, p <0.001), NICU admission (OR: 2.1, p <0.001), and pre-term birth (OR: 2.64, p <0.001). ICP was not associated with postpartum hemmorhage (OR: 1.31, p = 0.13), small for gestational age (OR: 0.87, p = 0.07), stillbirth (OR: 1.49, p = 0.29). Our results confirm the adverse effects of ICP on co-existing pregnancy complications, obstetric and neonatal outcomes. ICP in associated with severe complications including increased rates of preeclampsia, emergency C-sections, preterm births, l gestational periods and higher rates of NICU admissions. These results may assist healthcare professionals in formulating comprehensive care guidelines for expectant mothers and newborns.

multidisciplinary sciences
Bibliometric study on international research hotspots for hypertensive disorders of pregnancy

Jue LIU,Wei LI,Yong-qing WANG

DOI: https://doi.org/10.3969/j.issn.1673-5293.2017.03.014

2017-01-01

Abstract:Objective To grasp the international research hotspots of hypertensive disorder complicating pregnancy ( HDCP) and their distribution through bibliometric analysis and to provide reference for future research area on HDCP for domestic researchers .Methods Hypertensive disorders of pregnancy was used as mesh terms in searching of published international literatures related with HDCP disorders of pregnancy in Pubmed database .Then key words of literatures from 2005 to 2016 on pregnancy induced hypertension were retrieved by Bibliography Item Co-occurrence Mining System and topic word matrix was generated .Bi-clustering analysis of the matrix was carried out using gCLUTO 1.0 software and visual curve mountain graph and tree diagram were generated based on cluster analysis .Results Altogether 31084 literatures was included in Pubmed since 1945.After two small peaks (1945-1960, 1961 -1980), the number of published literatures showed an exponential increase .Besides China, United States, Britain, Japan, Germany, Italy and Canada and other countries were hot spots in the field of HDCP research .Results of cluster analysis showed that international research focus was mainly concentrated on six aspects , including treatment , epidemiology and risk factors , diagnosis and early prediction , genetic polymorphism , treatment and diagnosis on complications , physiopathology of HDCP .And early prediction of preeclampsia ( cluster 2) was core hotspot in recent years , with the largest number of literatures and highly consistent research theme compared to other hotspots .Secondary hotspot was treatment of HDCP.Conclusion Since the first literature in 1945, the number of literatures on hypertensive disorders of pregnancy has increased exponentially in recent years .International research hotspots are treatment , epidemiology and risk factors , diagnosis and early prediction , genetic polymorphism and physiopathology of HDCP .And early prediction of preeclampsia is the most core hotspot .
Placental Proteome Alterations in Women with Intrahepatic Cholestasis of Pregnancy.

Pei He,Furong Wang,Yan Jiang,Yi Zhong,Yongfei Lan,Shuqing Chen

DOI: https://doi.org/10.1016/j.ijgo.2014.03.035

2014-01-01

International Journal of Gynecology & Obstetrics

Abstract:OBJECTIVE:To investigate differences in the placental proteomes of women with intrahepatic cholestasis of pregnancy (ICP) and those with a normal pregnancy.METHODS:Ten pregnant women diagnosed with ICP were recruited at the First People's Hospital of Yuhang District from October 2011 to September 2012; 10 age-matched healthy pregnant women acted as controls. Total placental proteins were extracted and subjected to two-dimensional polyacrylamide gel electrophoresis followed by mass spectrometry to identify proteins that were differentially expressed in the two groups.RESULTS:In total, 37 protein spots with differentially expressed proteins were found. These comprised proteins involved in cytoskeleton activity, blood coagulation, and platelet activation as well as chaperones, heat shock proteins, RNA-binding and calcium-binding proteins, and various enzymes.CONCLUSION:The placentas of women with ICP displayed significant proteome differences compared with women with a normal pregnancy. The results indicate that a variety of mechanisms and proteins may contribute to the development of ICP. Further verification and research are required to elucidate the exact roles of these proteins in ICP pathogenesis.
Increased Serum Levels of Neopterin and Soluble Interleukin-2 Receptor in Intrahepatic Cholestasis of Pregnancy.

ZP Wang,MY Dong,HN Chu,J He

DOI: https://doi.org/10.1111/j.0001-6349.2004.00601.x

2004-01-01

Acta Obstetricia Et Gynecologica Scandinavica

Abstract:OBJECTIVES:The etiology of intrahepatic cholestasis of pregnancy (ICP), a pregnancy-specific complication, remains not completely understood. Some alterations of immunity in ICP were reported, but the profile of immune alteration was far from clarified. The aim of this investigation was to characterize the changes of serum levels of neopterin, a marker for the activation of macrophage, and soluble interleukin-2 receptor (sIL-2R), a marker for the activation of lymphocyte, in ICP.METHODS:Serum levels of neopterin and sIL-2R were assayed with enzyme linked immunosorbent assay (ELISA) in 30 patients with ICP and 30 normal pregnant women. Student's t-test was used for statistic analysis, and p < 0.05 was considered significant.RESULTS:Compared with control, serum levels of neopterin (p < 0.005) and sIL-2R (p < 0.05) were increased significantly in women with ICP.CONCLUSIONS:Activation of monocyte-macrophage and lymphocyte was demonstrated in ICP, and the participation of the activation of macrophage and lymphocyte in pathogenesis of the disease could be assumed.
Recreational Drug Slang: Identification of New Terms and Populating a Lexical Taxonomy Ontology

Mindy K Ross,Abhishek Kumar,M. Lah,Richard Y. Calvo,Mike Conway

Abstract:
Intrahepatic cholestasis of pregnancy - Are you listening?

Jenny Chambers

DOI: https://doi.org/10.1177/1753495X241244415

Abstract:Through their personal experience of having intrahepatic cholestasis of pregnancy (ICP), this paper covers the development of current understanding of ICP. It summarises how research and clinical practice was developed through clinicians and followed by the inception of an ICP research group in the 1990s. This group's work has led to a better understanding of the mechanisms behind ICP, the risk threshold for stillbirth, and a genomic understanding of the condition. It focuses on how collaborative work between the author and researchers led to the formation of a charity for ICP. Despite this, some obstetric healthcare professionals continue to provide misinformation about ICP to women and birthing people. Furthermore, the views of those affected by ICP, together with the research they present to clinicians, are being ignored. It highlights a need for those managing ICP to listen to their patients and to pay closer attention to the research being published.
Variability analysis of the human and mouse T-cell receptor β chains

L. Bougueleret,J. Claverie

DOI: https://doi.org/10.1007/BF00346527

Immunogenetics

Abstract:
Intrahepatic cholestasis of pregnancy: Review of six national and regional guidelines

Matthew J. Bicocca,Jeffrey D. Sperling,Suneet P. Chauhan

DOI: https://doi.org/10.1016/j.ejogrb.2018.10.041

2018-12-01

Abstract:Intrahepatic cholestasis of pregnancy (ICP) is a poorly understood disease of the late second or third trimester of pregnancy, typically associated with rapid resolution following delivery. It is characterized by pruritis, elevated serum bile acids, and abnormal liver function tests and has been linked to stillbirth, meconium passage, respiratory distress syndrome and fetal asphyxial events. The incidence is highly variable, dependent both on the ethnic makeup of the population as well as the diagnostic criteria being used. Management is challenging for clinicians, as laboratory abnormalities often lag behind clinical symptoms making diagnosis difficult. The American Congress of Gastroenterology, Government of Western Australia Department of Health, the Royal College of Obstetricians and Gynaecologists, Society for Maternal Fetal Medicine, European Association for the Study of the Liver, and South Australia Maternal and Neonatal Community of Practice have all released guidelines to address the risks, diagnosis and management of ICP. We performed a descriptive review of these guidelines along with a literature search to address conflicting recommendations and highlight new evidence. The variations in the guidelines reflect the heterogeneity of the literature and the challenges of diagnosing and managing ICP.

obstetrics & gynecology,reproductive biology
Evaluation of neopterin,soluble interleukin-2 receptor and T-helper cell in intrahepatic cholestasis of pregnancy

王浛知,金丽,董旻岳,王正平

DOI: https://doi.org/10.3969/j.issn.1001-4411.2007.09.011

2007-01-01

Abstract:Objective:To investigate the changes of serum neopterin and soluble interleukin-2 receptor (sIL-2R) and the alteration of Th1/Th2 balance in intrahepatic cholestasis of pregnancy (ICP).Methods:30 patients with ICP were recruited and 30 normal pregnant women served as control. Neopterin,sIL-2R,interleukin-2 and interleukin-10 in serum was determined by means of ELISA and RIA.Results:The serum levels of neopterin and sIL-2R in ICP increased significantly as compared with those in control (P<0.001 and P<0.05 respectively). Interleukin-2,inteleukin-10 and IL-2/IL-10 ratio were not significantly different between the two groups (P>0.5,P>0.2,P>0.05,respectively).Conclusion:Increased neopterin and sIL-2R as well as unaltered Th1/Th2 balance are demonstrated in ICP,which indicates activated cell-mediated immunity in ICP.
[Clinical analysis of fetal death cases in intrahepatic cholestasis of pregnancy].

Jing He,Lu Chen,Cheng Liang

DOI: https://doi.org/10.3760/cma.j.issn.0529-567x.2011.05.004

2011-01-01

Abstract:OBJECTIVE:To investigate the clinical features, critical laboratory parameters, and fetal monitoring methods in intrahepatic cholestasis of pregnancy (ICP). METHODS:A retrospective analysis of 21 cases of ICP suffered with fetal death in Women's hospital, School of Medicine, Zhejiang University from January 1999 to December 2010 were discussed. RESULTS:(1) The average age of ICP patients suffered with fetal death were (30.2 ± 4.6) years old. Among them, 4 cases were older than 35 years, six cases were multipara, one of them suffered stillbirth 2 year before. Twenty cases were singleton pregnancies and 1 case was twin pregnancy. (2) All 21 cases of fetal death occurred in the third trimester, 12 cases occurred before 37 weeks, 9 cases after 37 weeks.Nine cases were diagnosed by ultrasound in outpatient clinics, fetal heart beat disappeared in 9 patients after admission because of ICP, two disappeared after labor, one during anesthesia before emergent surgery. Perinatal mortality rate of ICP was 0.148% (21/14 184), and fetal death occurred from 29 to 41 weeks with an average gestational age of (33.8 ± 4.2) weeks. (3) Puritus occurred in all 21 cases while 11 of them had pruritus all over the body. Ten pregnant women felt the fetal movement decreased or disappeared before diagnosis of fetal death. The glycocholic acid levels increased in all of the 21 cases. Among them, glycocholic acid levels in 11 cases were (21.49 - 64.48) µmol/L, while in 10 cases were ≥ 64.48 µmol/L. Serum bile acid levels elevated in 16 cases which had been analyzed (the other 5 cases had not been checked), and the highest level reached 270 µmol/L. Serum alanine aminotransferase and aspartate aminotransferase were increased in 14 cases. Seven cases had their total bilirubin > 21 µmol/L, and 12 cases had their direct bilirubin levels significantly elevated. Among the 21 cases of ICP, 15 cases were in severe status, while the other 6 cases were mild. (4) Nine patients had no antepartum surveillance since fetal death were diagnosed before admission. The results of antepartum surveillance were as follows: 2 cases had nonreassuring nonstress test (NST), one had mild "V" type deceleration. Absence of diastolic flow in umbilical artery were found in 3 cases, and low fetal biophysical score was got in one case. (5) All 21 patients had vaginal delivery. Six of them delivered after natural contraction, and the remaining 14 cases delivered after oral intake of mifepristone and amniotic injection of ethacridine, or oxytocin induced labor within 48 hours, only one case delivered after additional dinoprostone suppositories. The appearance of fetus, placentas and membranes were normal, the lengths of umbilical cord were average. Four cases were found with cords binding the necks or the bodies. Eighteen cases had grade III amniotic fluid with meconium-stained, and 2 cases complicated by oligohydramnios. Ten cases had their fetuses and placentas examined by pathologist. Among them, one case had multiple malformations, no more obvious pathological abnormalities were found in other fetuses. Pathologic examination showed that fibrin deposited around chorion and deciduas basalis, large vessels accompanied by calcification, degeneration, hemorrhagic infarction, and increased focal syncytial nodules could be seen in all of the ten placentas. CONCLUSIONS:Fetal death in pregnant women with ICP often occurs after the contractions, Severe ICP may be a key factor that involved in the occurrence of fetal death. Up to now, there is no valid indicators in fetal monitoring, which can predict fetal death. Extensive assessment of the severity and careful antepartum surveillance should be achieved before timely termination of pregnancy.
Comprehensive Analysis of Quantitative Proteomics With DIA Mass Spectrometry and ceRNA Network in Intrahepatic Cholestasis of Pregnancy

Dajun Fang,Yan Fang,Weiqiang Zhang,Yun Xiang,Xi Cheng,Mingfeng Liang,Huimin Xia

DOI: https://doi.org/10.3389/fcell.2022.854425

2022-07-22

Abstract:Background: Intrahepatic cholestasis of pregnancy (ICP) is a pregnancy-specific complication characterized by pruritus without skin damage and jaundice. The poor perinatal outcomes include fetal distress, preterm birth, and unexpected intrauterine death. However, the mechanism of ICP leading to poor prognosis is still unclear. Methods: We analyzed 10 ICP and 10 normal placental specimens through quantitative proteomics of data-independent acquisition (DIA) to screen and identify differentially expressed proteins. GO, KEGG, COG/KOG, StringDB, InterProScan, Metascape, BioGPS, and NetworkAnalyst databases were used in this study. PITA, miRanda, TargetScan, starBase, and LncBase Predicted v.2 were used for constructing a competing endogenous RNA (ceRNA) network. Cytoscape was used for drawing regulatory networks, and cytoHubba was used for screening core nodes. The ICP rat models were used to validate the pathological mechanism. Results: GO, KEGG, and COG/KOG functional enrichment analysis results showed the differentially expressed proteins participated in autophagy, autophagosome formation, cofactor binding, JAK-STAT signaling pathway, and coenzyme transport and metabolism. DisGeNET analysis showed that these differentially expressed proteins were associated with red blood cell disorder and slow progression. We further analyzed first 12 proteins in the upregulated and downregulated differentially expressed proteins and incorporated clinicopathologic parameters. Our results showed HBG1, SPI1, HBG2, HBE1, FOXK1, KRT72, SLC13A3, MBD2, SP9, GPLD1, MYH7, and BLOC1S1 were associated with ICP development. ceRNA network analysis showed that MBD2, SPI1, FOXK1, and SLC13A3 were regulated by multiple miRNAs and lncRNAs. Conclusion: ICP was associated with autophagy. The ceRNA network of MBD2, SPI1, FOXK1, and SLC13A3 was involved in ICP progression, and these core proteins might be potential target.
Prevalence and risk factors of intrahepatic cholestasis of pregnancy in a Chinese population

Xing-Xing Gao,Meng-Ying Ye,Yan Liu,Jin-Yan Li,Li Li,Wei Chen,Xue Lu,Guiying Nie,Yuan-Hua Chen

DOI: https://doi.org/10.1038/s41598-020-73378-5

IF: 4.6

2020-10-01

Scientific Reports

Abstract:Abstract Studies on the risk factors for intrahepatic cholestasis of pregnancy (ICP) in a population-based cohort are lacking. We assess the prevalence and risk factors of ICP in a Chinese population. In this study, a cohort study was conducted that included 12,200 eligible pregnant women. The overall incidence of ICP in this cohort was 6.06%. With increasing maternal age, the incidence of ICP decreased in women younger than 30 years of age but increased in those older than 30. With increasing pre-pregnancy BMI, the incidence of ICP decreased if the pre-pregnancy BMI was less than 23 kg/m 2 but increased if it was 23 kg/m 2 or higher. Further analysis showed that the risk of ICP increased when maternal age was < 25 years (Adjusted RR 2.01; 95% CI 1.64–2.47) or ≥ 35 years (Adjusted RR 1.34; 95% CI 1.02–1.76). Furthermore, an increased risk of ICP was associated with pre-pregnancy underweight (adjusted RR 1.27; 95% CI 1.04–1.56), inadequate gestational weight gain (GWG) (adjusted RR 1.58; 95% CI 1.28–1.96), lower maternal education (adjusted RR 2.96; 95% CI 2.35–3.74), multiparity (adjusted RR 1.54; 95% CI 1.23–1.93), and twin/multiple pregnancies (adjusted RR 2.12; 95% CI 1.25–3.58). Maternal age (< 25 or ≥ 35 years), underweight, inadequate GWG, lower maternal education, multiparity, and twin/multiple pregnancies were identified as risk factors of ICP.

multidisciplinary sciences
Intrahepatic Cholestasis of Pregnancy is Associated with an Increased Risk of Gestational Diabetes and Preeclampsia

Congcong Liu,Jinsong Gao,Juntao Liu,Xietong Wang,Jing He,Jingxia Sun,Xiaowei Liu,Shixiu Liao

DOI: https://doi.org/10.21037/atm-20-4879

IF: 3.616

2020-01-01

Annals of Translational Medicine

Abstract:Background: Previous studies have shown that intrahepatic cholestasis of pregnancy (ICP) is associated with an increased incidence of adverse perinatal outcomes, and this supports the contention that ICP is associated with increased risk for both gestational diabetes mellitus (GDM) and preeclampsia. The purpose of this study was to review adverse maternal and perinatal outcomes of ICP in the Chinese population, and to investigate the association between ICP and GDM, as well as between ICP and preeclampsia. Methods: We conducted a retrospective cohort study in which we compared pregnancies affected by ICP with all other deliveries during the study period. Data from women with singleton pregnancies who delivered in 14 representative hospitals in China between October 1, 2016 and September 30, 2017 were collected from our database system. We then performed logistic regression analysis to determine the odds ratios (OR) and 95%CIs of the adverse pregnancy outcomes among women with or without ICP. Results: A total of 95,728 singleton births were induded in the study, and among these, 911 pregnancies were diagnosed as having ICP, resulting in an incidence of 0.95%. Women with ICP were more likely to have GDM [adjusted odds ratio (aOR), 1.406; 95% CI, 1.179-1.677; P<0.001] and preeclampsia (aOR, 2.241; 95% CI, 1.678-2.992; P<0.001) compared with those who did not have ICP. Women in the ICP group exhibited higher rates of scheduled cesarean deliveries (aOR, 3.527; 95% CI, 2.981-4.173; P<0.001) and cesarean deliveries during labor (aOR, 4.388; 95% CI, 1.815-10.612; P=0.027). Women with ICP were also more likely to have iatrogenic preterm delivery (aOR, 2.449; 95% CI, 1.92-3.122; P<0.001) and admission to the neonatal intensive care unit (aOR, 1.572; 95% CI, 1.318-1.874; P<0.001). There was no increased risk of stillbirth in the cohort of ICP cases (aOR, 0.430; 95% CI, 0.049-3.767; P=0.259). Conclusions: ICP was associated with an increased risk of GDM and preeclampsia in singleton pregnancies. Pregnancies with ICP therefore have significantly increased risks of adverse perinatal outcomes.
Diagnostic and prognostic value of blood inflammation and biochemical indicators for intrahepatic cholestasis of pregnancy in Chinese pregnant women

Mengjun Luo,Li Wang,Haibo Yao,Yizhou Wen,Dengcheng Cao,Wei Shen,Chenggui Liu

DOI: https://doi.org/10.1038/s41598-022-22199-9

IF: 4.6

2022-12-04

Scientific Reports

Abstract:Intrahepatic cholestasis of pregnancy (ICP) is a common liver disease during pregnancy, that has serious complications. This study aimed to compare the blood inflammation and biochemical markers of pregnant women with ICP in Southwest China and analyse their diagnostic value for ICP. A controlled cross-sectional study was conducted, and routine blood and biochemical indicators of 304 diagnosed ICP patients and 363 healthy pregnant women undergoing routine prenatal examination were assessed. The blood inflammatory indicators and biochemical indicators were compared between the ICP groups and normal groups. In this study, the levels of the ALT, AST, GGT, TBIL and DBIL biochemical indicators and the levels of WBC, neutrophils, NLR and PLR inflammatory indicators in the ICP group were significantly higher than those in healthy pregnant women ( p < 0.001). The PA and lymphocytes of the ICP group were significantly lower than those of the normal group ( p < 0.001). ROC curves showed that ALT and the NLR had higher predictive value for ICP. The GGT, TBA and NLR of pregnant women with ICP in the preterm group were significantly higher than those in the term group, and the combined NLR and TBA had a certain predictive value for preterm birth.

multidisciplinary sciences
Studies on Novel Diagnostic and Predictive Biomarkers of Intrahepatic Cholestasis of Pregnancy Through Metabolomics and Proteomics

Ruirui Dong,Ningzhen Ye,Shaojie Zhao,Gaoying Wang,Yan Zhang,Tiejun Wang,Ping Zou,Jing Wang,Tingting Yao,Minjian Chen,Conghua Zhou,Ting Zhang,Liang Luo

DOI: https://doi.org/10.3389/fimmu.2021.733225

IF: 7.3

2021-10-14

Frontiers in Immunology

Abstract:Background Intrahepatic cholestasis of pregnancy (ICP) usually occurs in the third trimester and is associated with increased risks in fetal complications. Currently, the exact mechanism of this disease is unknown. The purpose of this study was to develop potential biomarkers for the diagnosis and prediction of ICP. Methods We enrolled 40 pregnant women diagnosed with ICP and 40 healthy pregnant controls. The number of placental samples and serum samples between the two groups was 10 and 40 respectively. Ultra-performance liquid chromatography tandem high-resolution mass spectrometry was used to analyze placental metabolomics. Then, we verified the differentially expressed proteins and metabolites, both placental and blood serum, in the first, second, and third trimesters. Results Metabolomic analysis of placental tissue revealed that fatty acid metabolism and primary bile acid biosynthesis were enriched. In the integrated proteomic and metabolomic analysis of placental tissue, peroxisomal acyl-CoA oxidase 1 (ACOX1), L-palmitoylcarnitine, and glycocholic acid were found to be three potential biomarkers. In a follow–up analysis, expression levels of both placental and serum ACOX1, L-palmitoylcarnitine, and glycocholic acid in both placenta and serum were found to be significantly higher in third-trimester ICP patients; the areas under the ROC curves were 0.823, 0.896, and 0.985, respectively. Expression levels of serum ACOX1, L-palmitoylcarnitine, and glycocholic acid were also significantly higher in first- and second-trimester ICP patients; the areas under the ROC curves were 0.726, 0.657, and 0.686 in the first trimester and 0.718, 0.727, and 0.670 in the second trimester, respectively. Together, levels of the three aforementioned biomarkers increased the value for diagnosing and predicting ICP (AUC: 0.993 for the third, 0.891 for the second, and 0.932 for the first trimesters). Conclusions L-palmitoylcarnitine, ACOX1, and glycocholic acid levels taken together may serve as a new biomarker set for the diagnosis and prediction of ICP.

immunology
Circulatory Metabolomics Reveals the Association of the Metabolites With Clinical Features in the Patients With Intrahepatic Cholestasis of Pregnancy

Wenhu Liu,Qiang Wang,Jinxia Chang,Anup Bhetuwal,Nisha Bhattarai,Xin Ni

DOI: https://doi.org/10.3389/fphys.2022.848508

IF: 4

2022-07-11

Frontiers in Physiology

Abstract:Objective: Intrahepatic cholestasis of pregnancy (ICP) is associated with an increased risk of adverse pregnancy to the mother and fetus. As yet, the metabolic profiles and the association of the clinical features remain obscure. Methods: Fifty-seven healthy pregnant women and 52 patients with ICP were recruited in this study. Plasma samples were collected from pregnancies who received prenatal care between 30 and 36 weeks. Untargeted metabolomics to portray the metabolic profiles were performed by LC/MS. Multivariate combined with the univariate analysis was performed to screen out differential metabolites between the ICP and control groups. A de-biased sparse partial correlation (DSPC) network analysis of differential metabolites was conducted to explore the potential mutual regulation among metabolites on the basis of de-sparsified graphical lasso modeling. The pathway analysis was carried out using MetaboAnalyst. Linear regression and Pearson correlation analysis was applied to analyze correlations of bile acid levels, metabolites, newborn weights, and pregnancy outcomes in ICP patients. Results: Conspicuous metabolic changes and choreographed metabolic profiles were disclosed: 125 annotated metabolites and 18 metabolic pathways were disturbed in ICP patients. DSPC networks indicated dense interactions among amino acids and their derivatives, bile acids, carbohydrates, and organic acids. The levels of total bile acid (TBA) were increased in ICP patients with meconium-stained amniotic fluid (MSAF) compared with those without MSAF. An abnormal tryptophan metabolism, elevated long chain saturated fatty acids and estrone sulfate levels, and a low-antioxidant capacity were relevant to increased bile acid levels. Newborn weights were significantly associated with the levels of bile acids and some metabolites of amino acids. Conclusion: Our study revealed the metabolomic profiles in circulation and the correlation of the metabolites with clinical features in ICP patients. Our data suggest that disturbances in metabolic pathways might be associated with adverse pregnancy outcomes.

physiology
Clinical Management Guidelines for Intrahepatic Cholestasis of Pregnancy

Obstetrics Group of the Gynecology and Obstetrics Branch of Chinese Medical Association; Perinatal Medicine Branch of Chinese Medical Association,Xinyang Yu,Huixia Yang,Hongbo Qi,

DOI: https://doi.org/10.1097/fm9.0000000000000207

2024-01-01

Maternal-Fetal Medicine

Abstract:Abstract Intrahepatic cholestasis of pregnancy (ICP) is a significant gestational complication in late pregnancy, potentially leading to severe perinatal complications such as intrauterine fetal demise and preterm birth. The Obstetrics Group of the Gynecology and Obstetrics Branch and the Perinatal Medicine Branch of the Chinese Medical Association organized a panel of domestic experts to deliberate and propose recommendations based on domestic and international guidelines, recent evidence-based medical evidence about key clinical issues including risk factors, clinical manifestations, perinatal outcomes, diagnosis, severity grading, maternal and fetal monitoring, treatment methods, timing, and methods of pregnancy termination, and postpartum follow-up for ICP, with the aim to guide its clinical diagnosis, treatment, and management.

obstetrics & gynecology

Testing block subdivision algorithms on block designs

An omics review and perspective of researches on intrahepatic cholestasis of pregnancy

Unexplored topics in intrahepatic cholestasis of pregnancy: A review and bibliometric analysis

Intrahepatic cholestasis of pregnancy: insights into pathogenesis and advances in omics studies

Systematic review and meta-analysis: Evaluating the influence of intrahepatic cholestasis of pregnancy on obstetric and neonatal outcomes

Bibliometric study on international research hotspots for hypertensive disorders of pregnancy

Placental Proteome Alterations in Women with Intrahepatic Cholestasis of Pregnancy.

Increased Serum Levels of Neopterin and Soluble Interleukin-2 Receptor in Intrahepatic Cholestasis of Pregnancy.

Recreational Drug Slang: Identification of New Terms and Populating a Lexical Taxonomy Ontology

Intrahepatic cholestasis of pregnancy - Are you listening?

Variability analysis of the human and mouse T-cell receptor β chains

Intrahepatic cholestasis of pregnancy: Review of six national and regional guidelines

Evaluation of neopterin,soluble interleukin-2 receptor and T-helper cell in intrahepatic cholestasis of pregnancy

[Clinical analysis of fetal death cases in intrahepatic cholestasis of pregnancy].

Comprehensive Analysis of Quantitative Proteomics With DIA Mass Spectrometry and ceRNA Network in Intrahepatic Cholestasis of Pregnancy

Prevalence and risk factors of intrahepatic cholestasis of pregnancy in a Chinese population

Intrahepatic Cholestasis of Pregnancy is Associated with an Increased Risk of Gestational Diabetes and Preeclampsia

Diagnostic and prognostic value of blood inflammation and biochemical indicators for intrahepatic cholestasis of pregnancy in Chinese pregnant women

Studies on Novel Diagnostic and Predictive Biomarkers of Intrahepatic Cholestasis of Pregnancy Through Metabolomics and Proteomics

Circulatory Metabolomics Reveals the Association of the Metabolites With Clinical Features in the Patients With Intrahepatic Cholestasis of Pregnancy

Clinical Management Guidelines for Intrahepatic Cholestasis of Pregnancy